Yellow Fever Immunization Campaign Nears Completion In Kinshasa, WHO Says; Concerns Remain Over Wider Outbreak, Lack Of Vaccines

The Guardian: Fears of global yellow fever epidemic grow as vaccine stocks dwindle
“A last-ditch effort to prevent yellow fever spreading through Kinshasa in the Democratic Republic of the Congo and potentially developing into a global epidemic is to be launched using vaccines containing a fifth of the normal dose because the global stockpile is so low…” (Boseley, 8/16).

Reuters: Yellow fever vaccination drive in Congo’s capital hits target
“A vaccination campaign against yellow fever in Congo’s capital is almost complete, but the gains may be reversed by the looming rainy season and the spread of the disease to areas where people have not yet been vaccinated, the World Health Organization (WHO) said on Friday…” (Ross, 8/26).

Washington Post: As globe-threatening yellow fever epidemic explodes in Congo, people ask ‘where is the vaccine?’
“…Unlike Zika (or Ebola, and other reemerging threats), there already exists a yellow fever vaccine — one that’s cheap, lifelong, and highly efficacious. But advancements in the yellow fever approach plateaued almost seven decades ago, when success against the infection suppressed transmission — and concern…” (Baumgaertner, 8/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.